Haoming Zhou

3.4k total citations · 2 hit papers
72 papers, 2.6k citations indexed

About

Haoming Zhou is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Haoming Zhou has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Epidemiology and 23 papers in Immunology. Recurrent topics in Haoming Zhou's work include Liver Disease Diagnosis and Treatment (14 papers), Organ Transplantation Techniques and Outcomes (13 papers) and Autophagy in Disease and Therapy (10 papers). Haoming Zhou is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Organ Transplantation Techniques and Outcomes (13 papers) and Autophagy in Disease and Therapy (10 papers). Haoming Zhou collaborates with scholars based in China, United States and United Kingdom. Haoming Zhou's co-authors include Ling Lü, Xuehao Wang, Shun Zhou, Ling Lü, Wantong Su, Qi Wang, Qingfa Bu, Jinren Zhou, Zhuqing Rao and Ronald W. Busuttil and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Immunology and Cancer Research.

In The Last Decade

Haoming Zhou

69 papers receiving 2.5k citations

Hit Papers

Tumor metabolite lactate promotes tumorigenesis by modula... 2022 2026 2023 2024 2022 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haoming Zhou China 28 1.2k 808 643 401 382 72 2.6k
Qiang You China 30 1.5k 1.2× 1.0k 1.3× 562 0.9× 718 1.8× 321 0.8× 69 3.3k
Yiming Zhao China 31 1.4k 1.1× 545 0.7× 389 0.6× 679 1.7× 306 0.8× 102 2.9k
Han Wu China 31 808 0.7× 342 0.4× 533 0.8× 625 1.6× 330 0.9× 92 2.5k
Junfei Jin China 32 1.8k 1.5× 428 0.5× 353 0.5× 565 1.4× 285 0.7× 81 2.8k
Jianni Qi China 26 1.1k 0.9× 487 0.6× 402 0.6× 625 1.6× 152 0.4× 69 2.0k
Xingbin Hu China 20 1.2k 1.0× 607 0.8× 267 0.4× 523 1.3× 161 0.4× 65 2.4k
Min Feng China 29 1.6k 1.3× 391 0.5× 285 0.4× 887 2.2× 309 0.8× 112 2.9k
Gang Huang China 31 1.4k 1.2× 559 0.7× 351 0.5× 1.0k 2.5× 322 0.8× 86 2.8k
Fernando Vidal‐Vanaclocha Spain 34 1.6k 1.3× 942 1.2× 290 0.5× 487 1.2× 218 0.6× 72 3.1k

Countries citing papers authored by Haoming Zhou

Since Specialization
Citations

This map shows the geographic impact of Haoming Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoming Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoming Zhou more than expected).

Fields of papers citing papers by Haoming Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoming Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoming Zhou. The network helps show where Haoming Zhou may publish in the future.

Co-authorship network of co-authors of Haoming Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Haoming Zhou. A scholar is included among the top collaborators of Haoming Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoming Zhou. Haoming Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Qing, et al.. (2025). Macrophage ATG16L1 promotes liver regeneration after partial hepatectomy. JHEP Reports. 7(5). 101330–101330.
2.
Wang, Qi, Qingfa Bu, Zibo Xu, et al.. (2024). Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy. Clinical and Molecular Hepatology. 30(3). 515–538. 11 indexed citations
3.
Bu, Qingfa, Xiaozhang Xu, Qi Wang, et al.. (2024). ATG16L1 Depletion‐Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis. Mediators of Inflammation. 2024(1). 8831821–8831821. 1 indexed citations
4.
Su, Wantong, Rui Zhang, Qi Wang, et al.. (2023). TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling. JHEP Reports. 5(5). 100695–100695. 61 indexed citations
6.
Wang, Ping, et al.. (2023). Multiple sclerosing hemangiomas mimicking hepatocellular carcinoma: A case report. International Journal of Immunopathology and Pharmacology. 37. 1200410994–1200410994. 1 indexed citations
7.
Wang, Qi, Qingfa Bu, Mu Liu, et al.. (2022). XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression. JHEP Reports. 4(11). 100555–100555. 74 indexed citations
8.
Wang, Qi, Wei Song, Lei Li, et al.. (2021). miR-139-5p sponged by LncRNA NEAT1 regulates liver fibrosis via targeting β-catenin/SOX9/TGF-β1 pathway. Cell Death Discovery. 7(1). 243–243. 26 indexed citations
9.
Zhou, Haoming, Jing Zhang, Dan Jin, et al.. (2020). Isoform- and Cell Type–Specific Roles of Glycogen Synthase Kinase 3 N-Terminal Serine Phosphorylation in Liver Ischemia Reperfusion Injury. The Journal of Immunology. 205(4). 1147–1156. 4 indexed citations
10.
Zhou, Haoming, Shun Zhou, Yong Shi, et al.. (2020). TGR5/Cathepsin E signaling regulates macrophage innate immune activation in liver ischemia and reperfusion injury. American Journal of Transplantation. 21(4). 1453–1464. 32 indexed citations
11.
Zhou, Haoming, Jie Sun, Weizhe Zhong, et al.. (2020). Dexmedetomidine preconditioning alleviated murine liver ischemia and reperfusion injury by promoting macrophage M2 activation via PPARγ/STAT3 signaling. International Immunopharmacology. 82. 106363–106363. 31 indexed citations
12.
13.
Zhou, Shun, Jian Gu, Rui Liu, et al.. (2018). Spermine Alleviates Acute Liver Injury by Inhibiting Liver-Resident Macrophage Pro-Inflammatory Response Through ATG5-Dependent Autophagy. Frontiers in Immunology. 9. 948–948. 91 indexed citations
14.
Xia, Yongxiang, Haoming Zhou, Feipeng Zhu, et al.. (2017). Diagnosis and treatment of pulmonary cavity after liver transplantation. Annals of Translational Medicine. 5(15). 301–301. 1 indexed citations
15.
Haffner, Michael C., Jonathan B. Coulter, Raju R. Raval, et al.. (2016). Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation. Clinical Cancer Research. 22(13). 3310–3319. 33 indexed citations
16.
Wang, Kunpeng, Jian Gu, Xuhao Ni, et al.. (2016). CD25 signaling regulates the function and stability of peripheral Foxp3+ regulatory T cells derived from the spleen and lymph nodes of mice. Molecular Immunology. 76. 35–40. 10 indexed citations
17.
Ni, Xiaohua, Yonggang Zhang, Kenji Zennami, et al.. (2015). Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer–siRNA Chimeras in Human Tumor Xenografts. Molecular Cancer Therapeutics. 14(12). 2797–2804. 17 indexed citations
18.
Rao, Jianhua, Haoming Zhou, Guoqiang Li, et al.. (2014). Remain recipient partial liver during liver transplant after Hassab. Journal of Surgical Research. 189(2). 321–325. 3 indexed citations
19.
Xu, Geng, et al.. (2009). Interleukin‐6 is essential for Staphylococcal exotoxin B‐induced T regulatory cell insufficiency in nasal polyps. Clinical & Experimental Allergy. 39(6). 829–837. 25 indexed citations
20.
Williams, Jerry R., Yonggang Zhang, Haoming Zhou, et al.. (2008). A quantitative overview of radiosensitivity of human tumor cells across histological type and TP53 status. International Journal of Radiation Biology. 84(4). 253–264. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026